je.st
news
Pick Up Celgene After 9% Pullback - It's Ready
2015-06-20 19:05:23| Biotech - Topix.net
The oncology treatment sector is expected grow 7% annually over next five years, and Celgene is forecast to have high double-digit earnings growth annually over next several years. Celgene Corporation is seeing a lot of success from its bone marrow cancer treatment drug Revlimid among its other cancer fighting drug products.
Tags: its
ready
pick
pullback
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||